www.fgks.org   »   [go: up one dir, main page]
Skip to main content
SpringerLink
Log in

Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?

  • Critical Perspective
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiac conditions. Atrial fibrillation (AF) has been demonstrated to be the most frequent arrhythmia encountered in HCM patients. Research focusing on AF and embolic stroke in HCM patients has been sparse and the sample size of most studies is small. The prognostic significance of AF in HCM patients is still not well known. The aim of this article is to provide further understanding of the anti-coagulation requirement of HCM patients with AF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A et al (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218

    Article  CAS  PubMed  Google Scholar 

  2. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719–2747

    Article  PubMed  Google Scholar 

  3. Tian T, Wang Y, Sun K, Wang J, Zou Y, Zhang W et al (2013) Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy. Cardiology 126:258–264

    Article  PubMed  Google Scholar 

  4. Guttmann OP, Rahman MS, O’Mahony C, Anastasakis A, Elliott PM (2014) Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart 100:465–472

    Article  PubMed  Google Scholar 

  5. Losi MA, Betocchi S, Aversa M, Lombardi R, Miranda M, D’Alessandro G et al (2004) Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 94:895–900

    Article  PubMed  Google Scholar 

  6. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429

    Article  PubMed  Google Scholar 

  7. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ (2014) Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. J Am Heart Assoc 3:e001002

    Article  PubMed Central  PubMed  Google Scholar 

  8. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124:e783–e831

    Article  PubMed  Google Scholar 

  9. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524

    Article  CAS  PubMed  Google Scholar 

  10. Ozdemir O, Soylu M, Demir AD, Topaloglu S, Alyan O, Turhan H et al (2004) P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy. Int J Cardiol 94:163–166

    Article  PubMed  Google Scholar 

  11. Benchimol Barbosa PR, Barbosa EC, Bomfim AS, Ribeiro RL, Boghossian SH, Kantharia BK (2013) A practical score for risk stratification of embolic stroke in hypertrophic cardiomyopathy. Eur Heart J 34(suppl 1):2969

    Article  Google Scholar 

  12. Kizilbash AM, Heinle SK, Grayburn PA (1998) Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation 97:461–466

    Article  CAS  PubMed  Google Scholar 

  13. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ (Clinical research ed). 342:d124

    Article  PubMed Central  Google Scholar 

Download references

Conflict of interest

No conflicts of interest to declare.

Author information

Author notes

    Authors and Affiliations

    1. Department of Cardiology, Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Marlborough Street, Bristol, BS2 8HW, UK

      Antonio Frontera, H. Sekhon, E. R. Duncan & G. Thomas

    2. Department of Cardiology, University Hospitals Southampton NHS Foundation Trust, Southampton, UK

      D. G. Wilson

    Authors
    1. Antonio Frontera
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. D. G. Wilson
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. H. Sekhon
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. E. R. Duncan
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. G. Thomas
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Antonio Frontera.

    Additional information

    A. Frontera and D. Wilson contributed equally.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Frontera, A., Wilson, D.G., Sekhon, H. et al. Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?. Clin Res Cardiol 104, 799–802 (2015). https://doi.org/10.1007/s00392-015-0876-6

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00392-015-0876-6

    Keywords

    Search

    Navigation